🚀 VC round data is live in beta, check it out!
- Public Comps
- Lifecare
Lifecare Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lifecare and similar public comparables like Arcoma, Scandinavian Medical, Scandinavian Real Heart, Trinity Biotech and more.
Lifecare Overview
About Lifecare
Lifecare ASA focuses on the research, development, and commercialization of sensor technology for continuous monitoring of body analytes. Lifecare develops and licenses nanotechnology for medical use to facilitate the production and sale of medical devices. Its miniaturized sensor technology measures changes by reading osmotic pressure variations in a small chamber, and can, e.g., measure glucose and lactate levels by applying different chemical compositions. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.
Founded
2006
HQ

Employees
39
Website
Sectors
Financials (LTM)
EV
$23M
Lifecare Financials
Lifecare reported last 12-month revenue of $159K and negative EBITDA of ($11M).
In the same LTM period, Lifecare generated $96K in gross profit, ($11M) in EBITDA losses, and had net loss of ($11M).
Revenue (LTM)
Lifecare P&L
In the most recent fiscal year, Lifecare reported revenue of $12K and EBITDA of ($12M).
Lifecare expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $159K | XXX | $12K | XXX | XXX | XXX |
| Gross Profit | $96K | XXX | — | XXX | XXX | XXX |
| Gross Margin | 60% | XXX | — | XXX | XXX | XXX |
| EBITDA | ($11M) | XXX | ($12M) | XXX | XXX | XXX |
| EBITDA Margin | (6923%) | XXX | (98426%) | XXX | XXX | XXX |
| EBIT Margin | (7445%) | XXX | (112550%) | XXX | XXX | XXX |
| Net Profit | ($11M) | XXX | ($12M) | XXX | XXX | XXX |
| Net Margin | (6993%) | XXX | (103959%) | XXX | XXX | XXX |
| Net Debt | — | — | $5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Lifecare Stock Performance
Lifecare has current market cap of $13M, and enterprise value of $23M.
Market Cap Evolution
Lifecare's stock price is $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $23M | $13M | -0.1% | XXX | XXX | XXX | $-0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLifecare Valuation Multiples
Lifecare trades at 145.6x EV/Revenue multiple, and (2.1x) EV/EBITDA.
EV / Revenue (LTM)
Lifecare Financial Valuation Multiples
As of April 20, 2026, Lifecare has market cap of $13M and EV of $23M.
Equity research analysts estimate Lifecare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lifecare has a P/E ratio of (1.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV (current) | $23M | XXX | $23M | XXX | XXX | XXX |
| EV/Revenue | 145.6x | XXX | 1940.4x | XXX | XXX | XXX |
| EV/EBITDA | (2.1x) | XXX | (2.0x) | XXX | XXX | XXX |
| EV/EBIT | (2.0x) | XXX | (1.7x) | XXX | XXX | XXX |
| EV/Gross Profit | 242.7x | XXX | — | XXX | XXX | XXX |
| P/E | (1.2x) | XXX | (1.1x) | XXX | XXX | XXX |
| EV/FCF | (2.1x) | XXX | (1.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lifecare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Lifecare Margins & Growth Rates
Lifecare's revenue in the last 12 month grew by 335%.
Lifecare's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.
Lifecare's rule of 40 is 3001% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Lifecare's rule of X is 9543% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Lifecare Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 335% | XXX | 4361% | XXX | XXX | XXX |
| EBITDA Margin | (6923%) | XXX | (98426%) | XXX | XXX | XXX |
| EBITDA Growth | (35%) | XXX | (38%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 3001% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 9543% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 13898% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 60664% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 116136% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Lifecare Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Lifecare | XXX | XXX | XXX | XXX | XXX | XXX |
| Arcoma | XXX | XXX | XXX | XXX | XXX | XXX |
| Scandinavian Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Scandinavian Real Heart | XXX | XXX | XXX | XXX | XXX | XXX |
| Trinity Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Bionano Genomics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lifecare M&A Activity
Lifecare acquired XXX companies to date.
Last acquisition by Lifecare was on XXXXXXXX, XXXXX. Lifecare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Lifecare
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLifecare Investment Activity
Lifecare invested in XXX companies to date.
Lifecare made its latest investment on XXXXXXXX, XXXXX. Lifecare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Lifecare
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lifecare
| When was Lifecare founded? | Lifecare was founded in 2006. |
| Where is Lifecare headquartered? | Lifecare is headquartered in Norway. |
| How many employees does Lifecare have? | As of today, Lifecare has over 39 employees. |
| Is Lifecare publicly listed? | Yes, Lifecare is a public company listed on Oslo Børs. |
| What is the stock symbol of Lifecare? | Lifecare trades under LIFE ticker. |
| When did Lifecare go public? | Lifecare went public in 2018. |
| Who are competitors of Lifecare? | Lifecare main competitors are Arcoma, Scandinavian Medical, Scandinavian Real Heart, Trinity Biotech. |
| What is the current market cap of Lifecare? | Lifecare's current market cap is $13M. |
| What is the current revenue of Lifecare? | Lifecare's last 12 months revenue is $159K. |
| What is the current revenue growth of Lifecare? | Lifecare revenue growth (NTM/LTM) is 335%. |
| What is the current EV/Revenue multiple of Lifecare? | Current revenue multiple of Lifecare is 145.6x. |
| Is Lifecare profitable? | No, Lifecare is not profitable. |
| What is the current EBITDA of Lifecare? | Lifecare has negative EBITDA and is not profitable. |
| What is Lifecare's EBITDA margin? | Lifecare's last 12 months EBITDA margin is (6923%). |
| What is the current EV/EBITDA multiple of Lifecare? | Current EBITDA multiple of Lifecare is (2.1x). |
| What is the current FCF of Lifecare? | Lifecare's last 12 months FCF is ($11M). |
| What is Lifecare's FCF margin? | Lifecare's last 12 months FCF margin is (6948%). |
| What is the current EV/FCF multiple of Lifecare? | Current FCF multiple of Lifecare is (2.1x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.